Susquehanna International Group, LLP Evaxion Biotech A/S Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$0.48 - $1.33 $24,356 - $67,486
-50,742 Reduced 60.76%
32,774 $27,000
Q2 2023

Aug 11, 2023
SELL
$1.12 - $1.74 $39,430 - $61,258
-35,206 Reduced 29.65%
83,516 $109,000
Q1 2023

May 16, 2023
BUY
$1.03 - $1.8 $122,283 - $213,699
118,722 New
118,722 $134,000
Q4 2021

Feb 14, 2022
BUY
$4.0 - $12.68 $60,360 - $191,341
15,090 New
15,090 $67,000

Others Institutions Holding EVAX

# of Institutions
1
Shares Held
37.5K
Call Options Held
0
Put Options Held
0
View Full List

About Evaxion Biotech A/S

EVAX Quotes by TradingView
  • Ticker EVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,977,900
  • Market Cap $33.8M
  • Description
  • Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Ph...
More about EVAX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email